Publicaciones
-
Frongia AL, Natera-de Benito D, Ortez-Gonzalez CI, Alarcón M, Borrás A, Medina J, Vigo-Morancho M, Padrós N, Moya O, Armas J, Carrera-García L, Exposito-Escudero JM, Cuadras-Palleja D, Bernal S, Martorell-Sampol L, Colomer J and Nascimento-Osorio A.
Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II
NEUROMUSCULAR DISORDERS . 29(7): 517-524. Nº de citas: 15
-
Vidal-Falcó S, Brandi-Tarrau N, Pacheco-Fernández P, Maynou-Fernández J, Fernandez-Isern G, Xiol C, Pascual-Alonso A, Pineda M and Armstrong-Moron J.
The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . 23(4): 609-620. Nº de citas: 24
-
Pijuan-Marquilles J, Barceló C, Moreno DF, Maiques O, Sisó P, Marti RM, Macià A and Panosa A.
In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis
Frontiers in Cell and Developmental Biology . 7: 107-107. Nº de citas: 433
-
Carrera-García L, Natera-de Benito D, Dieterich K, de la Banda MGG, Felter A, Inarejos E, Codina-Bergadà A, Jou-Munoz C, Roldan-Molina M, Palau F, Hoenicka J, Pijuan-Marquilles J, Ortez-Gonzalez CI, Exposito-Escudero JM, Durand C, Nugues F, Jimenez-Mallebrera C, Colomer J, Carlier RY, Lochmüller H, Quijano-Roy S and Nascimento-Osorio A.
CHRNG-related nonlethal multiple pterygium syndrome: Muscle imaging pattern and clinical, histopathological, and molecular genetic findings
AMERICAN JOURNAL OF MEDICAL GENETICS PART A . 179(6): 915-926. Nº de citas: 12
-
Billingsley KJ, Barbosa IA, Bandrés-Ciga S, Quinn JP, Bubb VJ, Deshpande C, Botia JA, Reynolds RH, Zhang D, Simpson MA, Blauwendraat C, Gan-Or Z, Gibbs JR, Nalls MA, Singleton A, Ryten M, Koks S and International Parkinson’s Disease Genomics Consortium (IPDGC).
Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset
npj Parkinsons Disease . 5: 8-8. Nº de citas: 100
-
Martinez-Monseny T, Bolasell M, Callejón L, Cuadras-Palleja D, Freniche V, Itzep DC, Gassiot S, Arango P, Casas-Alba D, de la Morena E, Corral J, Montero-Sanchez R, Pérez-Cerdá C, Pérez-Dueñas B, Artuch-Iriberri R, Jaeken J, and the CDG Spanish Consortium and Serrano M.
AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG)
ANNALS OF NEUROLOGY . 85(5): 740-751. Nº de citas: 56
-
Reynolds RH, Botía J, Nalls MA, Hardy J, Gagliano Taliun SA, Ryten M, International Parkinson’s Disease Genomics Consortium (IPDGC) and System Genomics of Parkinson’s Disease (SGPD).
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability
npj Parkinsons Disease . 5: 6-6. Nº de citas: 73
-
Mollá B, Muñoz-Lasso DC, Calap P, Fernández-Vilata A, de la Iglesia-Vaya M, Pallardó FV, Moltó MD, Palau F and González-Cabo P.
Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model
NEUROTHERAPEUTICS . 16(2): 432-449. Nº de citas: 9
-
Martinez-Monseny T, Cuadras-Palleja D, Bolasell M, Muchart-Lopez J, Arjona-Fernandez C, Borregan M, Algrabli A, Montero-Sanchez R, Artuch-Iriberri R, Velázquez-Fragua R, Macaya A, Pérez-Cerdá C, Pérez-Dueñas B, Pérez B and Serrano M.
From gestalt to gene: early predictive dysmorphic features of PMM2-CDG
JOURNAL OF MEDICAL GENETICS . 56(4): 236-245. Nº de citas: 20
-
Montero-Sanchez R, Yubero-Siles D, Salgado MC, González MJ, Campistol-Plana J, O'Callaghan-Gordo M, Pineda M, Delgadillo V, Maynou-Fernández J, Fernandez-Isern G, Montoya C, Ruiz-Pesini E, Meavilla-Olivas SM, Neergheen V, Garcia-Cazorla A, Navas P, Hargreaves I and Artuch-Iriberri R.
Plasma coenzyme Q10 status is impaired in selected genetic conditions
SCIENTIFIC REPORTS . 9: 793-793. Nº de citas: 29